drugset / Trial / NCT01567657

Safety Study of Two Regimen for Sedation for Transesophageal Echocardiography

NCT01567657

Phase 2 Completed 200 enrolled Kantonsspital Münsterlingen
RandomizedSingle-groupSingle-blind

Summary

The purpose of this study is to determine whether sedation with a combination of pethidin hydrochlorid plus midazolam intravenously (i.v.) is superior to propofol i.v. alone in relation to blood pressure drops during an transesophageal echocardiographic examination (TEE).

Timeline

Start
2012-01
Primary completion
2013-01
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Midazolam Small molecule 1 mg Intravenous
Comparator Midazolam Small molecule 2 mg Intravenous
Comparator Midazolam Small molecule 7 mg Intravenous
Comparator Propofol Small molecule 10 mg Intravenous
Comparator Propofol Small molecule 20 mg Intravenous
Comparator Propofol Small molecule 30 mg Intravenous
Comparator Propofol Small molecule 40 mg Intravenous
Comparator Propofol Small molecule 50 mg Intravenous
Comparator Propofol Small molecule 60 mg Intravenous
Comparator pethidin hydrochlorid Unknown 25 mg Intravenous

Indications